Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer
Recruiting · NCT06883201 · Observational (researchers observe without assigning treatment) · Lead sponsor: Regina Elena Cancer Institute
View the official record on ClinicalTrials.gov →What this trial is about
Evaluation of the percentage of transfusions in patients with breast cancer undergoing surgery after preventive treatment with haematinics.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- age \> 18 years;
- patients diagnosed with histologically confirmed breast cancer and whether or not they have undergone neoadjuvant chemotherapy;
- patients who are candidates for destructive and reconstructive breast surgery or not;
- Hb values less than or equal to 11 g/dL and/or transferrin saturation less than or equal to 20%;
- written informed consent.
Exclusion criteria
- patients with known allergies to ferric carboxymaltose or its excipients;
- ferritin values greater than 500 ng/ml;
- patients unable to sign consent and comply with procedures.
Where it is running
1 location listed.
- "Regina Elena" National Cancer Institute - Rome, Italy